Search

Health Canada is advising Canadians about unauthorized health products that may pose serious health risks. The table is updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid…

The closure of a large infant formula manufacturing plant by Abbott Laboratories in the United States (manufacturer of Similac®Alimentum)®, has resulted in a global shortage of infant formula. Canada is experiencing a shortage of infant formulas designed…

August 25, 2019 For immediate release OTTAWA – Health Canada is reminding Canadians that plasma pens are not authorized for sale in Canada and that these devices may pose health risks. Health Canada is also underlining that consumers should be wary…

November 26, 2018 For immediate release OTTAWA – Health Canada is advising consumers that plasma pens (also known as “fibroblast” devices) promoted for cosmetic skin treatments such as eyelid lifts, wrinkle reduction and…

COMIRNATY received a Notice of Compliance (NOC) under the Food and Drug Regulations on September 16, 2021, replacing the previous authorization under the Interim Order. On March 15, 2022, COMIRNATY also received a NOC for an additional formulation…

Teva Canada Ltd. is recalling one lot each of Pharmasave Advanced Relief Eye Drops and Compliments Advanced Relief Eye Drops because of a packaging error. Some bottles may contain ingredients that are not listed on the label and that may pose health…

Apotex Inc. is recalling certain lots of Apo-Acyclovir (acyclovir) tablets, in 200 mg and 800 mg strengths, due to the presence of a nitrosamine impurity (N-nitrosodimethylamine [NDMA]) above the acceptable level. Apo-Acyclovir is a…

Health Canada is warning consumers not to use unauthorized health products seized from three herbal medicine stores in Calgary, Alberta, because they are labelled to contain prescription drugs and may pose serious health risks. The products include skin…

UPDATE: April 21, 2022 – Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity Pfizer Canada ULC is recalling all lots of the prescription drug Accupril (quinapril hydrochloride) in 10 mg, 20 mg and 40 mg strengths due to the…

Certain lots of hand sanitizers do not meet Health Canada requirements. Issues include: containing (or possibly containing) ingredients that are not permitted by Health Canada; containing undeclared impurities at elevated levels; improper…

Sotrovimab, 500 mg IV, is unlikely to maintain efficacy against the Omicron BA.2 subvariant. Sotrovimab demonstrates reduced in vitro neutralization against the Omicron BA.2 subvariant.   Audience  Healthcare professionals responsible…

EVUSHELD (tixagevimab and cilgavimab for injection) was authorized by Health Canada on April 14, 2022. In order to provide rapid access to EVUSHELD in the context of the global COVID-19 pandemic, AstraZeneca will distribute product vials and cartons with…

Health Canada is reminding Canadians of the risk of serious harm if children accidentally consume edible cannabis. Health Canada is aware of several cases of children being hospitalized, particularly after consuming products that are illegal and…

Health Canada has updated its 2019 and 2017 safety reviews on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare but serious cancer of the immune system that can develop next to a breast implant. This review found that there…

UPDATED INFORMATION – May 6, 2022 Further to the communication below, issued on March 15, 2022, regarding the potential for the presence of particulate matter in vials of Sodium Acetate Injection, USP (DIN 02139529) from lot 6126554, Fresenius Kabi…